Results
| PMID | 19620087 |
| Gene Name | FHIT |
| Condition | Endometriosis |
| Association |
Associated |
| Population size | 73 |
| Population details | 73 (58 patients with endometriosis, 15 patients with hysteromyoma) |
| Sex | Female |
| Associated genes | FHIT |
| Other associated phenotypes |
Endometriosis |
|
Nan Fang Yi Ke Da Xue Xue Bao. 2009 Jul;29(7):1479-81. Su, Gui-Dong| Ke, Yan| Yu, Yan-Hong| Zhang, Guang-Liang Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. suguidong@21cn.com OBJECTIVE: To detect the expression of fragile histidine triad in endometriosis and investigate the pathogenesis of endometriosis. METHODS: immunohistochemistry was used to examine the expression of Fhit in the eutopic and ectopic endometria of 58 patients with endometriosis and in the endometria in 15 patients with hysteromyoma. RESULTS: The intensity of Fhit expression decreased in the order of normal endometrium, eutopic endometrium in endometriosis group, and ectopic endometrium. In patients with endometriosis, Fhit expression in the eutopic and ectopic endometria in proliferative phase showed no significant difference from that in secretory phase (P>0.05). Fhit expression in the ectopic endometrium showed significant difference between different r-AFS stages. MOD of ectopic endometrium in stages I-II was significantly higher than that in stages III-IV (P<0.05), but Fhit expression in the eutopic endometrium showed no significant difference (P>0.05). MOD of ovarian endometriosis showed no difference with that of adenomyosis. CONCLUSIONS: Fhit may play an important role in the development of endometriosis. Mesh Terms: Acid Anhydride Hydrolases/*metabolism| Adult| Endometriosis/*metabolism/pathology| Endometrium/*metabolism| Female| Humans| Middle Aged| Neoplasm Proteins/*metabolism|DA 2013/03/21 06:00 |
|